It's an appeal. It's a prior authorization, It's wrapped in with the clinical trial. No, it's back to a prior authorization. It's Super-Conflated.
After hours on hold and multiple lateral passes yesterday, I thought that when I finally got a phone number and a reference number from a case manager for my local oncologist to use with clear instructions of what he needed to do, the path was clear to a yes or no.
Boy, was I naive. His nurse got the same polite run around that I did today.
But everyone (even me), is very sweet and tries to be oh so helpful.
Remember all I am trying for is authorization for the relatively cheap mandatory consult to assess whether I am a candidate for the trial, not for the pricey trial itself. I understand quite sensibly that once it is ascertained that I indeed qualify, OSU will then apply for the trial coverage, and that is the real critical action. I am quite confident that will work out. And I am very confident that I will be in the trial by February.
I suspect, again probably naively, that the authorization for the trial itself is a more traveled route and an easier path to navigate.
This is just a fun and informative diversion in learning how the other big blue (not IBM but Blue Shield or BS) works.
The trial is the goal. I can pay for the consult, but not the trial. This is the practice run. I am keeping detailed records. I am hoping that I don't need them.
I am keeping my eyes on that prize. For a chance for real durable disease control. The excitement of a healthy and lengthy old age, a new drug that offers a true truce with my leukemia: these joyful possibilities almost get lost in these side battles.
1 Comments:
I think you should lobby Dr. Farooqui at NIH to amend his protocol so that people like you could be entered into their PCI study!
Good Luck
Post a Comment
Subscribe to Post Comments [Atom]
<< Home